Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberWO2003057072 A8
Publication typeApplication
Application numberPCT/US2002/041748
Publication date8 Jul 2004
Filing date31 Dec 2002
Priority date31 Dec 2001
Also published asCA2471994A1, EP1469865A2, EP1469865A4, US7101862, US20030175327, US20060141018, US20080020026, WO2003057072A2, WO2003057072A3
Publication numberPCT/2002/41748, PCT/US/2/041748, PCT/US/2/41748, PCT/US/2002/041748, PCT/US/2002/41748, PCT/US2/041748, PCT/US2/41748, PCT/US2002/041748, PCT/US2002/41748, PCT/US2002041748, PCT/US200241748, PCT/US2041748, PCT/US241748, WO 03057072 A8, WO 03057072A8, WO 2003/057072 A8, WO 2003057072 A8, WO 2003057072A8, WO-A8-03057072, WO-A8-2003057072, WO03057072 A8, WO03057072A8, WO2003/057072A8, WO2003057072 A8, WO2003057072A8
InventorsKent C Cochrum, Susan Jemtrud
ApplicantAres Lab Llc, Kent C Cochrum, Susan Jemtrud
Export CitationBiBTeX, EndNote, RefMan
External Links: Patentscope, Espacenet
Hemostatic compositions and methods for controlling bleeding
WO 2003057072 A8
Abstract
The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g., cotton gauze, and a polysaccharide covalently linked to the cellulose, or a polysaccharide ionically cross-linked and in association with the article. Methods of making and using the hemostatic compositions are also provided.
Classifications
International ClassificationA61L15/00, A61K31/729, A61K31/721, A61K31/718, C08B1/00, C08B30/00, A61F, A61L17/00, A61B17/12, A61L15/16, A61P7/04, A61F13/00, A61K31/715
Cooperative ClassificationA61L2300/418, A61L15/225, A61L33/08, A61L15/28, A61L2300/232, A61L2400/04, A61L15/44
European ClassificationA61L15/22M, A61L15/28, A61L33/08, A61L15/44
Legal Events
DateCodeEventDescription
17 Jul 2003AKDesignated states
Kind code of ref document: A2
Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW
17 Jul 2003ALDesignated countries for regional patents
Kind code of ref document: A2
Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
10 Sep 2003121Ep: the epo has been informed by wipo that ep was designated in this application
30 Jun 2004WWEWipo information: entry into national phase
Ref document number: PA/a/2004/006438
Country of ref document: MX
Ref document number: 2471994
Country of ref document: CA
Ref document number: 2003557435
Country of ref document: JP
8 Jul 2004CFPCorrected version of a pamphlet front page
8 Jul 2004CR1Correction of entry in section i
Free format text: IN PCT GAZETTE 29/2003 UNDER (71) REPLACE "ARES MEDICAL, INC." BY "ARES LABORATORIES, LLC."
29 Jul 2004WWEWipo information: entry into national phase
Ref document number: 2002797532
Country of ref document: EP
27 Oct 2004WWPWipo information: published in national office
Ref document number: 2002797532
Country of ref document: EP